Serveur d'exploration Covid (26 mars) - Analysis (new)

Index « AbsEn.i » - entrée « drugs »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
drugging < drugs < dry  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]
Ident.Authors (with country if any)Title
000014 (2020) H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine][Potential antiviral therapeutics for 2019 Novel Coronavirus].
000041 (2020) J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine][Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].
000043 (2020) H Y Tian [République populaire de Chine][2019-nCoV: new challenges from coronavirus].
000061 (2020) Oriol Mitjà [Espagne] ; Bonaventura Clotet [Espagne]Use of antiviral drugs to reduce COVID-19 transmission.
000089 (2020) David CyranoskiThis scientist hopes to test coronavirus drugs on animals in locked-down Wuhan.
000115 (2020) Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000232 (2020) Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong]Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
000278 (2020) Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis]Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
000303 (2020) Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde]Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
000344 (2020) Md. Golzar Hossain [Bangladesh] ; Sharmin Akter ; Eriko Ohsaki ; Keiji UedaImpact of the Interaction of Hepatitis B Virus with Mitochondria and Associated Proteins
000427 (2020) Hongzhou Lu [République populaire de Chine]Drug treatment options for the 2019-new coronavirus (2019-nCoV).
000428 (2020) Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash MedhiDrug targets for corona virus: A systematic review
000430 (2020) Shibo JiangDon't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
000473 (2020) Michael DayCovid-19: European drugs agency to review safety of ibuprofen.
000530 (2020) Yingxia Liu [République populaire de Chine] ; Yang Yang [République populaire de Chine] ; Cong Zhang [République populaire de Chine] ; Fengming Huang [République populaire de Chine] ; Fuxiang Wang [République populaire de Chine] ; Jing Yuan [République populaire de Chine] ; Zhaoqin Wang [République populaire de Chine] ; Jinxiu Li [République populaire de Chine] ; Jianming Li [République populaire de Chine] ; Cheng Feng [République populaire de Chine] ; Zheng Zhang [République populaire de Chine] ; Lifei Wang [République populaire de Chine] ; Ling Peng [République populaire de Chine] ; Li Chen [République populaire de Chine] ; Yuhao Qin [République populaire de Chine] ; Dandan Zhao [République populaire de Chine] ; Shuguang Tan [République populaire de Chine] ; Lu Yin [République populaire de Chine] ; Jun Xu [République populaire de Chine] ; Congzhao Zhou [République populaire de Chine] ; Chengyu Jiang [République populaire de Chine] ; Lei Liu [République populaire de Chine]Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
000553 (2020) Murray Esler ; Danielle Esler [Australie]Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
000573 (2020) Dan Zhou [République populaire de Chine] ; Sheng-Ming Dai [République populaire de Chine] ; Qiang Tong [République populaire de Chine]COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
000584 (2020) Piercarlo Sarzi-Puttini [Italie] ; Valeria Giorgi [Italie] ; Silvia Sirotti [Italie] ; Daniela Marotto [Italie] ; Sandro Ardizzone [Italie] ; Giuliano Rizzardini [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie]COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
000585 (2020) Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande]COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.
000598 (2020) Ennio Giulio Favalli [Italie] ; Francesca Ingegnoli [Italie] ; Orazio De Lucia [Italie] ; Gilberto Cincinelli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie]COVID-19 infection and rheumatoid arthritis: Faraway, so close!
000687 (2019) Ya Zhao [République populaire de Chine] ; Limin Feng [République populaire de Chine] ; Lijuan Liu [République populaire de Chine] ; Ruizhi Zhao [République populaire de Chine]Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i -k "drugs" 
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i  \
                -Sk "drugs" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    new
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    drugs
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021